×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
SER – serina therapeutics, inc. (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
SER
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/11
04:47 pm
ser
Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry [Yahoo! Finance]
Low
Report
Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry [Yahoo! Finance]
12/11
04:15 pm
ser
Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry
Low
Report
Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry
12/10
04:30 pm
ser
Serina Therapeutics Submits Complete Response to FDA Clinical Hold Letter for SER-252 Program
Medium
Report
Serina Therapeutics Submits Complete Response to FDA Clinical Hold Letter for SER-252 Program
11/13
06:10 am
ser
Serina Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights
Low
Report
Serina Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights
11/3
06:05 am
ser
Serina Therapeutics Provides Regulatory Update on SER-252 Program
Medium
Report
Serina Therapeutics Provides Regulatory Update on SER-252 Program
10/8
11:00 am
ser
Serina Therapeutics Launches Enhanced Corporate Communications Platform to Strengthen Engagement with Patients, Clinicians, and Investors
Low
Report
Serina Therapeutics Launches Enhanced Corporate Communications Platform to Strengthen Engagement with Patients, Clinicians, and Investors
10/6
04:47 pm
ser
Serina Therapeutics Draws First $5 Million Funding Tranche to Support Registrational Trial of SER-252 in Parkinson's Disease [Yahoo! Finance]
Low
Report
Serina Therapeutics Draws First $5 Million Funding Tranche to Support Registrational Trial of SER-252 in Parkinson's Disease [Yahoo! Finance]
10/6
04:15 pm
ser
Serina Therapeutics Draws First $5 Million Funding Tranche to Support Registrational Trial of SER-252 in Parkinson’s Disease
Low
Report
Serina Therapeutics Draws First $5 Million Funding Tranche to Support Registrational Trial of SER-252 in Parkinson’s Disease
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/17
07:57 pm
ser
Form 4 Serina Therapeutics, For: Dec 16 Filed by: Moreadith Randall
High
Report
Form 4 Serina Therapeutics, For: Dec 16 Filed by: Moreadith Randall
12/16
06:59 pm
ser
Form 4 Serina Therapeutics, For: Dec 12 Filed by: Moreadith Randall
Low
Report
Form 4 Serina Therapeutics, For: Dec 12 Filed by: Moreadith Randall
12/12
12:48 pm
ser
Form 4 Serina Therapeutics, For: Dec 11 Filed by: Moreadith Randall
Medium
Report
Form 4 Serina Therapeutics, For: Dec 11 Filed by: Moreadith Randall
12/11
04:11 pm
ser
Form 4 Serina Therapeutics, For: Dec 09 Filed by: Moreadith Randall
Low
Report
Form 4 Serina Therapeutics, For: Dec 09 Filed by: Moreadith Randall
12/10
04:17 pm
ser
Form 8-K Serina Therapeutics, For: Dec 10
Low
Report
Form 8-K Serina Therapeutics, For: Dec 10
12/4
07:56 pm
ser
Form 4 Serina Therapeutics, For: Dec 02 Filed by: Moreadith Randall
Medium
Report
Form 4 Serina Therapeutics, For: Dec 02 Filed by: Moreadith Randall
11/26
05:22 pm
ser
Form 4 Serina Therapeutics, For: Nov 25 Filed by: Moreadith Randall
Medium
Report
Form 4 Serina Therapeutics, For: Nov 25 Filed by: Moreadith Randall
11/25
09:20 pm
ser
Form 4 Serina Therapeutics, For: Nov 24 Filed by: Moreadith Randall
Medium
Report
Form 4 Serina Therapeutics, For: Nov 24 Filed by: Moreadith Randall
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: